Abstract
Cancer immunotherapy is a rapidly evolving and paradigm shifting treatment modality that adds a strong tool to the collective cancer treatment arsenal. It can be effective even for late stage diagnoses and has already received clinical approval. Tumors are known to not only avoid immune surveillance but also exploit the immune system to continue local tumor growth and metastasis. Because of this, most immunotherapies, particularly those directed against solid cancers, have thus far only benefited a small minority of patients. Early clinical substantiation lends weight to the claim that cancer immunotherapies, which are adaptive and enduring treatment methods, generate much more sustained and robust anticancer effects when they are effectively formulated in nanoparticles or scaffolds than when they are administered as free drugs. Engineering cancer immunotherapies using nanomaterials is, therefore, a very promising area worthy of further consideration and investigation. This review focuses on the recent advances in cancer immunoengineering using nanoparticles for enhancing the therapeutic efficacy of a diverse range of immunotherapies. The delivery of immunostimulatory agents to antitumor immune cells, such as dendritic or antig...Continue Reading
Citations
Dec 7, 2018·International Journal of Molecular Sciences·Suchithra Poilil SurendranYong Yeon Jeong
Mar 17, 2019·Journal of Clinical Medicine·Praveena Velpurisiva, Prakash Rai
Oct 27, 2018·Medicines·Purushottam LamichhaneNarottam Lamichhane
Aug 6, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Fernando Novio
Dec 18, 2018·Investigational New Drugs·Maurizio VialeGraziella Vecchio
Sep 25, 2020·Nanomedicine·Pablo Hernández-CamareroMacarena Perán
Mar 17, 2020·Drug Delivery and Translational Research·Arpit BhargavaPradyumna Kumar Mishra
Oct 20, 2018·JCI Insight·Farideh OrdikhaniReza Abdi
Oct 1, 2019·Current Pharmaceutical Design·Alessandra IscaroMunitta Muthana
Oct 3, 2018·Biomaterials Research·Wooram ParkDong Keun Han
Nov 3, 2020·Future Oncology·Deeksha G Lahori, Pegah Varamini
Mar 29, 2019·Redox Biology·Sin Yee GunSiew Cheng Wong
Mar 4, 2020·ACS Nano·Paul L ChariouNicole F Steinmetz
Apr 4, 2020·International Immunopharmacology·Vida HashemiFarhad Jadidi-Niaragh
Oct 18, 2019·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sharon Wei Ling LeeValeria Chiono
Apr 2, 2021·International Journal of Nanomedicine·Tobias Achu MuluhJingBo Wu
Aug 24, 2020·Biotechnology Progress·Pourya NasirmoghadasMohammad Amin Jadidi Kouhbanani
Nov 14, 2020·Journal of Nanoscience and Nanotechnology·Lei WeiYing Meng
Jul 25, 2019·Journal of Medicinal Chemistry·Anas AhmadRehan Khan
Sep 10, 2021·Molecular Pharmaceutics·Priyanka VermaVirander Singh Chauhan